drugset / Trial / NCT03855189

Safety and Efficacy of Mometasone Furoate (SCH 032088) vs Beclomethasone Dipropionate or Placebo in Seasonal Allergic Rhinitis (C93-013)

NCT03855189

Phase 3 Completed 345 enrolled Organon and Co
RandomizedParallel-groupTriple-blindTreatment

Summary

The objectives of this study are to determine the safety and efficacy in seasonal allergic rhinitis of a four-week course of mometasone furoate compared to beclomethasone dipropionate or placebo.

Timeline

Start
1993-08-23
Primary completion
1993-10-08
Completion
1993-10-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Mometasone furoate Other / unclassified 200 ug Intranasal
Comparator beclomethasone dipropionate Other / unclassified 168 ug Intranasal